Basics Dyne Therapeutics, Inc. IPO Date: September 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $3.12B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.26% Avg Daily Range (30 D): $0.84 | 4.08% Avg Daily Range (90 D): $0.52 | 3.11% Institutional Daily Volume Avg Daily Volume: .8M Avg Daily Volume (30 D): 2.75M Avg Daily Volume (90 D): 2.52M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 81 Avg Trade Size (Sh.) (90 D): 87 Institutional Trades Total Inst.Trades: 2,156 Avg Inst. Trade: $2.49M Avg Inst. Trade (30 D): $2.11M Avg Inst. Trade (90 D): $1.98M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.17M Avg Closing Trade (30 D): $6.25M Avg Closing Trade (90 D): $4.82M Avg Closing Volume: 221.77K     News Dec 10, 2025 @ 2:42 AM Dyne Therapeutics Announces Pricing of Upsized $35... Source: Dyne Therapeutics Dec 9, 2025 @ 9:34 PM Biggest Market Movers Today, Dec. 9: WRBY, DYN, & ... Source: Dan Caplinger Oct 27, 2025 @ 10:17 PM Why Dyne Therapeutics Stock Crushed the Market on ... Source: Eric Volkman Sep 29, 2025 @ 12:35 PM Dyne Therapeutics Receives Orphan Drug Designation... Source: Globe Newswire Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.66 $-.76 $-.97 Diluted EPS $-3.66 $-.76 $-.97 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -423.8M $ -108.04M $ -110.86M Operating Income / Loss $ -449.16M $ -113.89M $ -115.79M Cost of Revenue $ $ $ Net Cash Flow $ 41.53M $ 88.58M $ 12.85M PE Ratio